News | November 23, 2008

Deborah Heart and Lung Center Begins Using Impella Device for High-Risk Cath Lab Patients

November 24, 2008 - Deborah Heart and Lung Center in Browns Mills, NJ said this week it successfully debuted the new Impella LP 2.5 minimally-invasive, catheter-based cardiac assist device in high-risk patients undergoing cardiac interventions.

The Impella 2.5, made by Abiomed, received FDA approval in June and is the world’s smallest heart pump. It is inserted through the skin in the cath lab via the femoral artery into the left ventricle of the heart. Up to 2.5 liters of blood per minute can then be continuously pumped from the left ventricle into the ascending aorta, providing the heart with active support in critical situations. With this steady blood flow, patients who were too critical to receive a cardiac intervention can now have life-saving treatment, Deborah officials said. Deborah is the first hospital in south Jersey to use this technology.

“Our first use of the Impella device for high risk PCI went very smoothly and successfully,” said Dr. Tommy Ng who heads up Deborah’s Impella team. “This offers a wide range of possibilities for patients who previously were not candidates for a cardiac intervention. This device has the potential to bring a fundamental shift for patients in the cath lab.”

“We are excited about this new technology,” said Dr. Manu Rajachandran, director of Deborah’s cardiac catheterization laboratory. “This will give us the ability to reach patients who were previously too medically fragile to undergo procedures which could save their lives. It is gratifying once again to be at the cutting-edge in medicine.”

Deborah Heart and Lung Center is a 139-bed teaching hospital that specializes in the diagnosis and treatment of congenital and acquired heart, lung and vascular diseases in adults, as well as providing outpatient cardiology services for children.

For more information: www.deborah.org

Related Content

Medtronic HeartWare HVAD System Approved for Destination Therapy
Technology | Ventricular Assist Devices (VAD)| October 04, 2017
October 4, 2017 — Medtronic received U.S.
Abiomed Receives FDA PMA Approval for Impella RP for Right Heart Failure
Technology | Ventricular Assist Devices (VAD)| September 28, 2017
Abiomed Inc. recently received U.S. Food and Drug Administration (FDA) pre-market approval (PMA) for the Impella RP ...
Abbott Receives FDA Approval for HeartMate 3 Left Ventricular Assist System
Technology | Ventricular Assist Devices (VAD)| August 29, 2017
Abbott announced it has received U.S. Food and Drug Administration (FDA) approval for its Full MagLev HeartMate 3 Left...
Pre-PCI Impella 2.5 Insertion Improves Survival in Left Main Coronary Artery Heart Attacks
News | Ventricular Assist Devices (VAD)| June 30, 2017
Abiomed Inc. announced the recent publication of a peer-reviewed retrospective study on hemodynamic support with the...
Heartware HVAD recall for its ventricular assist device from Medtronic
Feature | Ventricular Assist Devices (VAD)| May 05, 2017
May 5, 2017 — Medtronic Mechanical Circulatory Support is expanding its recall of its HeartWare Ventricular Assist De
Videos | Ventricular Assist Devices (VAD)| April 14, 2017
A discussion with William O'Neill, M.D., FACC, FSCAI, medical director of the Center for Structural Heart Disease at
Henry Ford Hospital, Detroit Cardiogenic Shock Initiative, Impella pump, ACC.17 clinical study
News | Ventricular Assist Devices (VAD)| April 03, 2017
Hospitals can dramatically increase heart attack survival rates in patients suffering cardiogenic shock by providing...
Metro Detroit cardiologists, increased heart attack survival rate, Impella heart pump, Detroit Cardiogenic Shock Initiative
News | Ventricular Assist Devices (VAD)| March 09, 2017
Metro Detroit cardiologists from five health systems have joined together to increase residents’ survival rate from...
Impella 2.5 heart pump, high-risk PCI, HRPCI, acute kidney injury risk, AKI, Circulation Research study, Abiomed
News | Ventricular Assist Devices (VAD)| March 09, 2017
A new study published in Circulation Research finds use of hemodynamic support with the Impella 2.5 heart pump during...
James Ward, LVAD surgery, left ventricular assist device, UAB, University of Alabama at Birmingham
News | Ventricular Assist Devices (VAD)| March 08, 2017
Congestive heart failure patients at the University of Alabama at Birmingham (UAB) now have reason for optimism with a...
Overlay Init